SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-085435
Filing Date
2013-11-18
Accepted
2013-11-18 16:30:58
Documents
3
Period of Report
2013-11-12
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-19023_128k.htm 8-K 29373
2 EX-3.1 a13-19023_12ex3d1.htm EX-3.1 69972
3 EX-3.2 a13-19023_12ex3d2.htm EX-3.2 186391
  Complete submission text file 0001104659-13-085435.txt   286841
Mailing Address 2 MERCER ROAD NATICK MA 01760
Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 131227345
SIC: 2834 Pharmaceutical Preparations